Biomarkers impact precision medicine several different ways. They improve molecular diagnostics, integrate diagnostics and therapeutics, and facilitate drug discovery and development.
We’re keeping track of upcoming conferences, both for biomarkers as well as for personalized medicine, precision medicine and companion diagnostics. See the list below for details.
|Biomarker Summit 2017||https://www.gtcbio.com/conferences/biomarkers-summit-overview||2017-03-20||
The Biomarker Summit 2017 is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.
A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.
|Precision Medicine World Conference (PMWC)||http://www.pmwcintl.com/2017sv/||2017-01-23||
Co-hosted with Stanford Health Care, UCSF, and Intermountain Healthcare in Silicon Valley, PMWC* 2017 SV will gather close to 1500 multidisciplinary attendees and key stakeholders from the business, government, healthcare delivery, research and technology arenas to examine the advances and challenges of precision medicine through a practical lens.
*Formerly known as the Personalized Medicine World Conference.
|8th Annual Personalized & Precision Medicine Conference||http://personalizedmedicinepartnerships.com||2016-10-12||
One of the longest running conferences in the personalized/precision medicine space, Arrowhead's 8th Annual Personalized & Precision Medicine Conference is once again returning to the San Francisco Bay Area, on October 12th-13th. With the renewed focus on precision medicine stemming from President Obama’s 2015 initiative and multiple advances in the field on a variety of fronts, this year’s conference promises to expand your thinking and put you front and center to hear from key players and stakeholders in the field.
|11th Annual Biomarkers Congress 2016||http://www.biomarkers-congress.com/||2016-02-25||
Oxford Global is proud to present its 11th Annual Biomarkers Congress taking place on the 25th & 26th February 2016 in Manchester. Our renowned congress will bring together over 250 attendees from pharmaceutical and biotechnology companies as well as academia. Going into its 11th year, Europe’s leading biomarkers congress will include representatives from the top pharmaceutical companies including AstraZeneca, Roche, BMS, Merck, AbbVie and top service provide companies including QuartzBio, MesoScaleDiscovery, LGC, Almac and more. Our expert speaker panel will also consist of renowned academics and smaller pharmaceutical companies who will bring their unique stories to the programme.
|Personalized Medicine World Conference (PMWC) 2016 Silicon Valley||http://2016sv.pmwcintl.com/||2016-01-24||
Co-hosted with Stanford Health Care and UCSF in Silicon Valley, PMWC 2016 Silicon Valley will gather close to 1200 multidisciplinary attendees and key stakeholders from the business, government, healthcare delivery, research and technology arenas to examine the advances and challenges of personalized medicine through a practical lens.
Chaired by visionary Dr. Atul Butte of UCSF, session themes include:
|The Biomarker Conference||http://www.mnmconferences.com/the-biomarker-conference-florida.html||2015-12-10||
At 'The Biomarker Conference' to be held on 10 - 11 December 2015 in Orlando, Florida, USA 150+ biomarker experts will be gathering to discuss emerging pathways and breakthroughs in biomarker discovery and successful validation in consort with the regulatory guidelines and evolving cost-effective technologies that can help increase success rates in novel biomarker discovery and approvals for clinical utility.
|Personalized Medicines & Biomarkers 2015||http://www.virtueinsight.com/pharma/Personalised-Medicines--Biomarkers-2015/||2015-12-02||
With the onset of the genomic era and increase in clinical molecular analysis, more and more, clinicians and researchers are clearly defining multiple disease subtypes for diseases that were once thought to be singular in cause. This is opening the door to the discovery and development of highly effective and targeted diagnostics and therapies that result in better patient outcomes and the reduction in use of generalised treatments with severe side effects. Despite these benefits the regulatory and financial systems are not yet in place to enable this revolution in healthcare to flourish and there are many hurdles to overcome before Personalised medicine can become commonplace. At this conferfence, you will benefit from the expert knowledge of leaders into omics and disease research who are currently working towards a future where medical interventions are more precise, more targeted and are resulting in better patient outcomes. You will hear from those that are currently discovering and developing therapies, with companion diagnostics, and from the professionals who are responsible for personalised medical products that have already hit the market. There will also be discussions involving industry and regulatory bodies on the improvements and challenges of personalised medicine and its practical impact on the future of healthcare.
|The 7th Annual Personalized & Precision Medicine Conference||http://www.personalizedmedicinepartnerships.com||2015-10-05||
Arrowhead's 7th Annual Personalized & Precision Medicine Conference is coming to Baltimore in October, just prior to the American Society for Human Genetics Annual Meeting. The conference will be exploring the ways in which Personalized & Precision Medicine is reshaping healthcare. This conference brings together multiple stakeholders, including payers, molecular diagnostics companies, genome analysis/interpretation companies, clinicians and many others in order to provide attendees with a holistic view of the personalized medicine landscape. As the field evolves, so has the Annual Personalized Medicine Conference. This year's conference will continue to examine the components that are integral to driving personalized medicine into the future.